Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
05/2005
05/05/2005US20050095705 Cell comprising replication-competent adenovirus vector for use as tool in generating gene therapeutic vectors; tissue directed therapy
05/05/2005US20050095704 Using nuclear transplantaion to transfer preferential nuclear material into enucleated animal oocyte; tissue engineering; gene therapy
05/05/2005US20050095703 Generating progenitor cells for use in prevention and treatment of cell proliferative, neurodegenerative and pancreatic disorders; regenerative medicine; tissue engineering
05/05/2005US20050095701 Transplanting conditionally-immortalized dorsal root ganglion progenitor cells into mammal to generate peripheral nervous system (PNS) for treatment and prevention of nervous system disorders
05/05/2005US20050095692 Generation and recovering of preferential viral particles; obtain cells, infect with virus, extract virus from cells using detergent, recover virus
05/05/2005US20050095681 Intracellular modulators of apoptopic cell death pathways
05/05/2005US20050095249 Protein markers for lung cancer and use thereof
05/05/2005US20050095232 Vaginal care composition
05/05/2005US20050095231 Transduction; gene therapy; replacing capsid with chimeric molecule containing heterologous trimerization motif and stabilized scFv ligand; host cells
05/05/2005US20050095230 For treatment of cancer or virus infection (HIV)
05/04/2005EP1527177A2 Muc-1 antigen with reduced number of vntr repeat units
05/04/2005EP1527161A2 Stem cells derived from adipous tissue and differentiated cells derived from said cells
05/04/2005EP1527159A1 Probiotic propionibacterium jensenii 702
05/04/2005EP1527087A2 Recombinant vesicular stomatitis virus vaccines for viral hemorrhagic fevers
05/04/2005EP1527085A2 Antigens and their use as diagnostics and vaccines against species of plasmodium
05/04/2005EP1465493A4 Cultured and encapsulated pancreatic stem cells
05/04/2005EP1297121B1 Purging of cells using viruses
05/04/2005EP1109925B1 Recombinant adenovirus for tissue specific expression in heart
05/04/2005EP0973529B1 Essential oil composition
05/04/2005EP0966969B1 Anti-stress drugs and functional foods having anti-stress effects
05/04/2005EP0804734B1 Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood
05/04/2005DE20023649U1 Synergistic active agent combination of colostrum product, minerals and herbal component, useful as or in medicaments, foodstuffs, food supplements or cosmetics, e.g. for skin treatment
05/04/2005CN1612756A Composition and method for treatment of wounds
05/04/2005CN1612691A Methods and compositions for correction of cardiac conduction disturbances
05/04/2005CN1612688A Anti-pathogenic composition useful in blood preservation
05/04/2005CN1611598A Human foetus pancreatic stem cell line and its establishing method
05/04/2005CN1611597A Rat marrow MSC invivo transplanting directional differentiation into retina structure
05/04/2005CN1611261A Medicinal preparation of muscular amino acids and nucleosides for injection and its preparing method
05/04/2005CN1611227A Egg white activity aspiration extraction and activity measuring technique
05/04/2005CN1200090C Ostrica bone medicinal liquor and preparation method thereof
05/04/2005CN1199697C Method for producing bio-artificial transplant
05/04/2005CN1199690C Thrombosis resisting composition
05/04/2005CN1199688C Growth hormone for ovarian functional cell and its prepn
05/04/2005CN1199687C Method for extracting gonad stimulating hormone from pregnant mare blood
05/04/2005CN1199679C Medicine for nourishing yin and fortifying kidney, benefiting qi and fortifying spleen, and its preparation method
05/04/2005CN1199675C Mother medicine
05/04/2005CN1199672C Chinese medicine for preventing and curing cancer
05/04/2005CN1199670C Chinese medicine for treating leukodema
05/04/2005CN1199669C Medicine for curing cervicitis and preparing method thereof
05/04/2005CN1199666C Powdered medicine for treating intractable ulcer
05/04/2005CN1199662C Medicine for curing peptic ulcer and its preparation method
05/04/2005CN1199660C Powdered medicnie 'shaotangsan' for treating burn and scald
05/04/2005CN1199657C Anticancer ointment
05/04/2005CN1199654C Hydrolyzation process of pear power suitable for ophthalmic medication
05/03/2005US6887987 DNA encoding the human serine protease T
05/03/2005US6887857 Microparticle protection of therapeutic agents
05/03/2005US6887706 Method of in vitro differentiation of transplantable neural precursor cells from primate embryonic stem cells
05/03/2005US6887704 A cell population cultured ex-vivo in a culture medium under conditions permitting cells of cell population to proliferate and at the same time reducing capacity of cells in utilizing copper, hence expanded yet not further differentiated
05/03/2005US6887674 Artery- and vein-specific proteins and uses therefor
05/03/2005US6887490 Use in the delivery of therapeutic agents to selected tissues and advantageously has the potential to repair/replace damaged tissue
05/03/2005US6887489 Propionibacterium P-63 for use in direct fed microbials for animal feeds
05/03/2005US6887474 Compositions and methods for producing vascular occlusion
05/03/2005US6887466 Activating the population of T cells and stimulating an accessory molecule on the surface of the T cells with a ligand; HIV immunotherapy; T cells can be genetically transduced and used for immunotherapy
05/03/2005US6887465 Combined with ingestable support comprising milk, yogurt, curd, fermented milks, cereals, powders, and/or infant formula; prevents intestinal colonization and infection of epithelial cells
05/03/2005US6887463 Recombinant viral vector encoding a human very low density lipoprotein (VLDL) receptor, operatively linked to regulatory sequences directing expression in a hepatocyte; familial hypercholesterolemia or hyperlipidemia
05/03/2005US6886568 Method for fabricating cell-containing implants
05/03/2005CA2486473A1 Vaginal care composition
05/03/2005CA2294686C Malleable paste for filling bone defects
05/03/2005CA2154652C Pharmaceutical and dermocosmetic compositions containing equine colostrum
04/2005
04/28/2005WO2005038454A1 In vitro method for the diagnosis of cardiovascular functionality of bone marrow precursor cells (bmp) and/or circulation precursor cells derived from blood (bdp)
04/28/2005WO2005038430A2 Viral fibers
04/28/2005WO2005038016A1 Cartilage replacement implant and method for producing a cartilage replacement implant
04/28/2005WO2005038014A1 Isolation of stem cell-like cells and use thereof
04/28/2005WO2005038012A2 Cartilage and bone repair and regeneration using postpartum-derived cells
04/28/2005WO2005037995A2 Use of cox-2 inhibitor to prevent t-cell anergy induced by dendritic cell therapy
04/28/2005WO2005037984A1 Cell handling device, human tissue regeneration composition, and human tissue regeneration method
04/28/2005WO2005037854A2 Immunogenic peptides
04/28/2005WO2005037322A1 Oncogene therapeutic drug
04/28/2005WO2005037321A1 Oncogene therapeutic drug
04/28/2005WO2005037248A1 Glycoprotein and/or glycomacropeptide containing preparations for medical uses
04/28/2005WO2005037225A2 Methods for treating disorders of neuronal deficiency with bone marrow-derived cells
04/28/2005WO2005037188A2 Therapeutic agent for periodontal disease
04/28/2005WO2005037144A2 Methods and compositions for growing corneal endothelial and related cells on biopolymers and creation of artifical corneal transplants
04/28/2005WO2005036989A1 Health food containing hyaluronic acid and dermatan sulfate
04/28/2005WO2005007811A3 Injection of bone marrow-derived cells and medium for angiogenesis
04/28/2005WO2005005481A3 Combination therapy for gastroenteric diseases caused by microorganisms
04/28/2005WO2005001079A3 Soft tissue repair and regeneration using postpartum-derived cells
04/28/2005WO2004098492A3 Trans-golgi network-associated processes, methods and compositions related thereto
04/28/2005WO2004075988A3 Methods of immunomodulation in animals
04/28/2005WO2004037188A3 Cardiac muscle regeneration using mesenchymal stem cells
04/28/2005WO2004020601A3 Neurogenesis from hepatic stem cells
04/28/2005WO2003087392A3 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
04/28/2005WO2003041568A3 A three-dimensional matrix for producing living tissue equivalents
04/28/2005WO2002072013A8 Method of treating malignancies through induction of blood immune responses
04/28/2005US20050090693 Clusianon derivatives; anticarcinogenic, antitumor and viricidal agents; mixture with mitogen-activated protein (MAP) kinase inhibitors
04/28/2005US20050090489 An alpha hydroxy acid or a retinoid as a bacterial fermentation product of a novel Streptomyces strain; topical antiwrinkle agents
04/28/2005US20050090480 preventing malaria comprising administering drugs that inhibition of growth of the malarial parasite, plasmodium falciparum, along with phosphono derivatives and/or other drugs; parasiticides
04/28/2005US20050090440 Tumour treating combinations, compositions and methods
04/28/2005US20050090424 Administering concurrent with cell grafting surgery using insulin producing stem cells
04/28/2005US20050090004 Stem cell maturation for all tissue lines
04/28/2005US20050090002 Serum free medium for chondrocyte-like cells
04/28/2005US20050090000 Novel human 7TM protein and polynucleotides encoding the same
04/28/2005US20050089999 Method for the production and purification of adenoviral vectors
04/28/2005US20050089985 Rescue of canine distemper virus from cdna
04/28/2005US20050089887 Novel human ion channel proteins
04/28/2005US20050089843 Polyclonal antibody specific for mannose-terminated viral envelope protein for use in detection and prevention of viral diseases
04/28/2005US20050089608 Exposing blood to hydrolase forming hydrolysate, enriching cmplexes by ultrafiltration in order to remove uncomplexed peptides; centrifuging second hydrolysate, mixing with soda,
04/28/2005US20050089578 Methods and devices for tissue repair
04/28/2005US20050089552 Silk fibroin fiber bundles for matrices in tissue engineering
04/28/2005US20050089538 Carcinoembryonic antigen (CEA); administering a humanized Class III, anti-CEA, monoclonal antibody to treat cancer; complementarity-determining regions (CDR) of given amino acid sequences; diagnostic and therapeutic conjugates; transformed cells